»À¾Ï Ä¡·á ½ÃÀå ±Ô¸ð : À¯Çüº°, Ä¡·áº°, Ä¡·á Á¦°øÀÚº°, ¿¹Ãø(2024-2032³â)
Bone Cancer Treatment Market Size - By Type (Primary, [Osteosarcoma, Chondrosarcoma], Secondary), Treatment (Targeted and Immunotherapy [Denosumab, Imatinib], Chemotherapy [Doxorubicin, Cisplatin]), Treatment Provider & Forecast, 2024 - 2032
»óǰÄÚµå : 1532531
¸®¼­Ä¡»ç : Global Market Insights Inc.
¹ßÇàÀÏ : 2024³â 05¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 226 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,850 £Ü 7,017,000
PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,050 £Ü 8,753,000
PDF & Excel (Multi User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,350 £Ü 12,081,000
PDF & Excel (Enterprise User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ »À¾Ï Ä¡·á ½ÃÀåÀº 2024-2032³â CAGR 5%¸¦ ±â·ÏÇϸç, Á¤È®ÇÑ Å½Áö¸¦ °¡´ÉÇÏ°Ô ÇÏ´Â °ÍÀ¸·Î »À¾Ï °ü¸®¿¡ Çõ¸íÀ» ÃÊ·¡ÇÏ´Â º¸´Ù ¿ì¼öÇÑ Áø´Ü ±â¼ú¿¡ ÀÇÇØ »ó½ÂÇÕ´Ï´Ù.

¹Ì±¹¾ÏÇùȸ(ACS)ÀÇ º¸°í¿¡ µû¸£¸é Áö³­ 10³â°£ ÷´Ü ¿µ»ó Áø´Ü ±â¼úÀÇ »ç¿ëÀº ¾à 15% Áõ°¡ÇÏ¿© Á¶±â Áø´ÜÀ» ´Ã¸®°í °ü¸® °á°ú¸¦ °³¼±ÇÏ´Â µ¥ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

Áø´Ü ±â¼úÀÇ Çõ½ÅÀ¸·Î Á¾¾çÀÇ Á¤È®ÇÑ À§Ä¡ ÆÄ¾Ç°ú À¯ÀüÀÚ ÇÁ·ÎÆÄÀϸµÀÌ ¿ëÀÌÇØÁ® ȯÀÚ °³°³ÀÎÀÇ Çʿ信 ¸Â´Â Ä¡·á °èȹÀ» ¼¼¿ì´Â µ¥ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù. Á¶±â ¹ß°ßÀº Ä¡·á ¼ºÀûÀ» ³ôÀÌ°í »ýÁ¸À²À» Çâ»ó½Ãŵ´Ï´Ù. ¶ÇÇÑ È¯ÀÚµéÀÇ ¸ÂÃãÇü Ä¡·á¿¡ ´ëÇÑ ¼±È£µµ º¯È­¿Í ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õÀÇ Àû±ØÀûÀÎ Á¢±Ù ¹æ½ÄÀº ÇâÈÄ ¼ö³â°£ ¾÷°è ¿ªÇÐÀ» °­È­ÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

ÀÌÂ÷ ¾Ï ºÐ¾ß´Â ¿ø¹ß¼º ¾ÏÀÇ ÀüÀ̰¡ ¸¹±â ¶§¹®¿¡ 2032³â±îÁö µÎµå·¯Áø CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. À¯¹æ¾Ï, Àü¸³¼±¾Ï°ú °°Àº ¿ø¹ß¼º ¾Ï ȯÀÚµéÀº Ãʱâ Ä¡·áÀÇ Çõ½ÅÀ¸·Î ÀÎÇØ ´õ ¿À·¡ »ì°Ô µÇ¸é¼­ ÀÌÂ÷¼º °ñ¾ÏÀÌ Å« °ü½É»ç·Î ¶°¿À¸£°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¯È­·Î ÀÎÇØ »À ÀüÀ̸¦ Ç¥ÀûÀ¸·Î ÇÏ´Â Àü¹® Ä¡·áÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÇ·á ¿µ»ó Áø´Ü ¹× ¸ð´ÏÅ͸µÀÇ °³¼±À¸·Î ÀÌÂ÷¼º °ñ¾ÏÀÇ ¹ß°ßÀÌ Çâ»óµÇ¾î Á¶±â °³ÀÔÀÌ °¡´ÉÇØÁ³½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀº ÀÌÂ÷¼º °ñ¾Ï Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

È­Çпä¹ý ºÐ¾ß´Â »õ·Î¿î È­Çпä¹ýÁ¦ÀÇ È¿´É°ú °¡¿ë¼ºÀÌ Áõ°¡ÇÔ¿¡ µû¶ó 2032³â±îÁö °ñ¾Ï Ä¡·á ½ÃÀå¿¡¼­ ÁÖ¸ñÇÒ ¸¸ÇÑ Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌµé ¾àÁ¦´Â ±¹¼Ò °ñ¾Ï°ú ÀüÀ̼º °ñ¾Ï ¸ðµÎ¿¡¼­ Çâ»óµÈ Ä¡·á °á°ú¸¦ º¸¿©ÁÜÀ¸·Î½á ȯÀڵ鿡°Ô º¸´Ù È¿°úÀûÀÎ Ä¡·á ¿É¼ÇÀ» Á¦°øÇÕ´Ï´Ù. È­Çпä¹ýÀº Á¾¾ç Å©±â¸¦ ÁÙÀÌ°í º´ÀÇ ÁøÇàÀ» ¾ïÁ¦ÇÏ´Â °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ½À´Ï´Ù. ¶ÇÇÑ º´¿ë¿ä¹ý ¹× °³º°È­µÈ È­Çпä¹ý ¿ä¹ýÀÇ ¹ßÀüÀº Ä¡·á È¿°ú¸¦ Çâ»ó½Ã۰í ÀÌ ºÐ¾ßÀÇ ¼ºÀåÀ» °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù.

À¯·´ÀÇ °ñ¾Ï Ä¡·á ½ÃÀåÀº °í·ÉÈ­¿Í °ñ¾Ï À¯º´·ü Áõ°¡·Î ÀÎÇØ 2024-2032³â ³î¶ó¿î CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Áö¿ªÀº ÀÇ·á ÀÎÇÁ¶ó°¡ Àß °®Ãß¾îÁ® ÀÖ°í, Ä¡·á¹ýµµ ¹ßÀüÇϰí ÀÖ½À´Ï´Ù. ÷´Ü ¿¬±¸¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡¿Í Á¾ÇÕÀûÀÎ ÀÇ·á ¼­ºñ½º Á¦°ø¿¡ ´ëÇÑ ÁýÁßÀûÀÎ ³ë·ÂÀ¸·Î ȯÀÚµéÀÇ Ä¡·á °á°ú°¡ °³¼±µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÎ½Ä °³¼±°ú Á¶±â ¹ß°ß ÇÁ·Î±×·¥À¸·Î Áø´ÜÀ²ÀÌ ³ô¾ÆÁö¸é¼­ È¿°úÀûÀÎ Ä¡·á ¼Ö·ç¼ÇÀÇ Çʿ伺ÀÌ ´ëµÎµÇ°í ÀÖ½À´Ï´Ù. ÀÇ·á ½Ã½ºÅÛÀÌ ¹ßÀüÇϰí ÀÚ¿øÀÌ È®´ëµÊ¿¡ µû¶ó À¯·´¿¡¼­ ÷´Ü °ñ¾Ï Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä´Â °è¼Ó Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå °³¿ä

Á¦3Àå ¾÷°è ÀλçÀÌÆ®

Á¦4Àå °æÀï ±¸µµ

Á¦5Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : À¯Çüº°, 2021-2032³â

Á¦6Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : Ä¡·áº°, 2021-2032³â

Á¦7Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : Ä¡·á Á¦°øÀÚº°, 2021-2032³â

Á¦8Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : Áö¿ªº°, 2021-2032³â

Á¦9Àå ±â¾÷ °³¿ä

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Bone Cancer Treatment Market will experience a 5% CAGR between 2024 and 2032, ascended by better diagnostic techniques that revolutionize bone cancer management by enabling accurate detection. According to the American Cancer Society (ACS) reports, the use of advanced imaging techniques has increased by about 15% over the past decade, contributing to a rise in early-stage diagnoses and improved management outcomes.

The diagnostic innovations facilitate precise tumor localization and genetic profiling, which help in tailoring treatment plans to individual patient needs. Early detection boosts treatment outcomes as well as enhances survival rates. Further, the shifting preference for personalized treatment among patients and proactive approach by healthcare providers will augment the industry dynamics in the coming years.

The overall bone cancer treatment market is classified based on type, treatment, treatment provider, and region.

The secondary segment will register a remarkable CAGR through 2032, due to the prevalence of metastasis from primary cancers. As patients with primary cancers, such as breast or prostate cancer, live longer due to innovations in initial treatments, secondary bone cancer is a significant concern. This shift results in a higher need for specialized treatments targeting bone metastases. Improvements in medical imaging and monitoring have strengthened the detection of secondary bone cancers, leading to earlier intervention. These factors contribute to the thriving demand for secondary bone cancer treatments.

The chemotherapy segment will clutch a notable bone cancer treatment market share by 2032, because of the increasing efficacy and availability of novel chemotherapy agents. These agents are showing improved outcomes in managing both localized and metastatic bone cancer, providing patients with more effective treatment options. Chemotherapy is known to reduce tumor size and control disease progression. Additionally, advancements in combination therapies and personalized chemotherapy regimens are enhancing treatment efficacy, escalating segment growth.

Europe bone cancer treatment market will record an impressive CAGR from 2024 to 2032, owing to an aging population and increased prevalence of bone cancer. The region boasts enhanced healthcare infrastructure and advancements in treatment options. The inflowing investment in cutting-edge research and focus on offering comprehensive care are resulting in improved patient outcomes. Additionally, increased awareness and early detection programs are leading to higher diagnosis rates, fueling the need for effective treatment solutions. As healthcare systems evolve and resources expand, the demand for advanced bone cancer treatments will continue its upward trajectory in Europe.

Table of Contents

Chapter 1 Methodology & Scope

Chapter 2 Executive Summary

Chapter 3 Industry Insights

Chapter 4 Competitive Landscape, 2023

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

Chapter 6 Market Estimates and Forecast, By Treatment, 2021 - 2032 ($ Mn)

Chapter 7 Market Estimates and Forecast, By Treatment Provider, 2021 - 2032 ($ Mn)

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

Chapter 9 Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â